Skip to content

Clinical trials

Observational Small Cell Lung Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Observational Clear all

140 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20011
20021
20031
20041
20053
20066
20076
20086
20095
20106
20112
20125
20131
20143
20152
20165
20176
20182
20196
20208
20217
20228
20238
202411
202514
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56
Recruiting33
Unknown status19
Active, not recruiting9
Terminated8
Not yet recruiting7
Withdrawn6
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Peking Union Medical College Hospital4
Vanderbilt-Ingram Cancer Center4
Addario Lung Cancer Medical Institute3
Alliance for Clinical Trials in Oncology3
Case Comprehensive Cancer Center3
National Cancer Institute (NCI)3
SWOG Cancer Research Network3
Stanford University3
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma140
Carcinoma, Non-Small-Cell Lung70
Lung Neoplasms60
Colorectal Neoplasms15
Head and Neck Neoplasms15
Breast Neoplasms14
Pancreatic Neoplasms14
Colonic Neoplasms13
Carcinoma, Hepatocellular11
Esophageal Neoplasms11

Trials

Showing 51 to 75 of 140. Each trial links to its page on Pharma Observatory.

40 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.